Immutep is listed on the Australian Stock Exchange (ASX:IMM) and on the NASDAQ Global Market (NASDAQ:IMMP) in the U.S. (ADR's).
We are a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, with operations in Europe, Australia, and the U.S.
We are the global leader in the understanding of and in the development of therapeutics that modulate Lymphocyte Activation Gene-3 (“LAG-3”), a cell surface molecule which plays a vital role in regulating T cells and which was discovered by our Chief Scientific Officer and Chief Medical Officer Dr. Frederic Triebel.
Our objective is to harness and strengthen the power of patients’ immune systems through therapeutic intervention for the benefit of patients’ health. We have one pre-clinical and three clinical LAG-3 product candidates under development, including two antibodies for modulating immune responses in autoimmunity and cancer, through pharmaceutical partnerships, with Novartis and GlaxoSmithKline.
Our lead product candidate is eftilagimod alpha (LAG-3Ig or IMP321), a first-in-class antigen presenting cell (APC) activator currently being investigated in clinical trials as a treatment (in combination with chemotherapy or immune therapy) for breast cancer and melanoma.
Latest Media Releases
14/02/2024 09:12:00
SYDNEY, AUSTRALIA – 14 February 2024 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing nov…
Latest News
Market Reports /
by Peter Milios -
11 months ago
16 May 2023 - The Reserve Bank's minutes for May indicate that the central bank is committed to reducing inflation. The Board expressed its determination to take the necessary acti…
Market Reports /
by Peter Milios -
A year ago
17 Apr 2023 - At the closing bell, the S&P/ASX 200 was 0.27 per cent higher at 7,381.50, led by gains in the financials and real estate sectors.
Market Reports /
by Peter Milios -
A year ago
17 Apr 2023 - Nine out of the eleven sectors are trading higher today. Information technology is surging on the back of gains from WiseTech Global (ASX:WTC), Xero (ASX:XRO), and Al…
Market Reports /
by Peter Milios -
A year ago
31 Mar 2023 - At the closing bell, the S&P/ASX 200 was 0.78 per cent higher at 7,177.80, led by the materials sector, which saw BHP Group's (ASX:BHP) shares rise by 2.5 per cent.
Market Reports /
by Peter Milios -
A year ago
31 Mar 2023 - At noon, the S&P/ASX 200 is 0.71% higher at 7,173, with materials and healthcare sectors leading the gains. Syrah Resources (ASX:SYR), Block (ASX:SQ2), and De Grey Mi…
Market Reports /
by Peter Milios -
A year ago
14 Mar 2023 - At the closing bell, the S&P/ASX 200 was 1.4 per cent lower at 7,008.9, a three-month low. The fall was mainly due to concerns about a financial crisis after the coll…
Market Reports /
by Peter Milios -
A year ago
14 Mar 2023 - Earlier today, the S&P/ASX 200 stock index of Australia experienced a decline of 2.1 per cent and hit a new low of 6956.7, which is close to its lowest point of the y…
Interviews /
by Tim McGowen -
A year ago
01 Mar 2023 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses data from SITC, the strategy to take Efti to market and milestones for 2023.
Market Reports /
by Peter Milios -
A year ago
06 Feb 2023 - All sectors besides Energy and Materials are trading lower today, after the US sectors fell on Friday due to a strong jobs report, which caused some investors to worr…
Market Reports /
by Peter Milios -
A year ago
30 Jan 2023 - The global race for lithium, a commodity crucial for the electric vehicle (EV) industry, has intensified as German Chancellor Olaf Scholz signed an agreement with Arg…
Market Reports /
by Peter Milios -
A year ago
08 Dec 2022 - Goldman Sachs have extended their bearish views on lithium, believing that the prices are expected to decline from the second half of 2023.
Market Reports /
by Lauren Hayes -
A year ago
08 Dec 2022 - The Australian market is still unnerved over concerns about a possible US recession. Energy is weighing down the benchmark over fears demand for oil will be impacted …
Market Reports /
by Peter Milios -
A year ago
06 Dec 2022 - The ASX has closed 0.47 per cent lower after the Reserve Bank of Australia delivered its eighth interest rate hike in a row, lifting the cash rate 25 basis higher to …
Market Reports /
by Lauren Hayes -
A year ago
06 Dec 2022 - The Australian market has followed Wall Street’s negative lead overnight after US markets sold off on fears that the Fed will keep increasing interest rates. Also wei…
Market Reports /
by Peter Milios -
A year ago
29 Nov 2022 - Singaporean iron ore futures have soared above the US$100 per tonne for the first time since September, resulting in gains for ASX-listed iron ore companies.
Market Reports /
by Peter Milios -
A year ago
29 Nov 2022 - The global economic outlook is shaky, as growing protests in the world's largest manufacturing nation are creating a new level of uncertainty for the economy.
Interviews /
by Tim McGowen -
A year ago
28 Nov 2022 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the LAG-3 landscape, the company's portfolio of therapies, encouraging data from the 2022 SI…
Market Reports /
by Lauren Hayes -
A year ago
14 Nov 2022 - Last week’s gains have not continued with the same momentum this morning. Materials, up 3.4 per cent, is bolstering the local market following a rise in commodity pri…
